| Medical management and prevention of motor complications in Parkinson's disease SD Aradi, RA Hauser Neurotherapeutics 17 (4), 1339-1365, 2020 | 75 | 2020 |
| Istradefylline – a first generation adenosine A2A antagonist for the treatment of Parkinson’s disease P Jenner, A Mori, SD Aradi, RA Hauser Expert Review of Neurotherapeutics 21 (3), 317-333, 2021 | 67 | 2021 |
| Ischemic stroke associated with calcitonin gene-related peptide inhibitor therapy for migraine: a case report S Aradi, E Kaiser, B Cucchiara Journal of Stroke and Cerebrovascular Diseases 28 (10), 104286, 2019 | 44 | 2019 |
| The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenant PA LeWitt, SD Aradi, RA Hauser, O Rascol Parkinsonism & Related Disorders 80, S54-S63, 2020 | 39 | 2020 |
| Predicting severity of Huntington's disease with wearable sensors BH Scheid, S Aradi, RM Pierson, S Baldassano, I Tivon, B Litt, ... Frontiers in Digital Health 4, 874208, 2022 | 5 | 2022 |
| Decision-Making in Adult Neurology, E-Book B Cucchiara, RS Price Elsevier Health Sciences, 2020 | 4 | 2020 |
| Clinical Outcomes from Directional Deep Brain Stimulation in Parkinson’s Disease Patients: A Retrospective Analysis (1018) A Shub, YB Bezchlibnyk, DA Smith, T Malapira, WW Miller, Y Huang, ... Neurology 94 (15_supplement), 1018, 2020 | 1 | 2020 |
| Current use of neurotoxins for alleviating symptoms of cervical dystonia S Aradi, RA Hauser Expert Review of Neurotherapeutics, 1-11, 2024 | | 2024 |
| Automatic classification of abnormal movement in Huntington's disease using wearable sensors and machine learning S Aradi, R Pierson, B Scheid, S Baldassano, B Litt, P Gonzalez-Alegre MOVEMENT DISORDERS 35, S643-S643, 2020 | | 2020 |
| Clinical Reasoning: A man with rapidly ascending paralysis J Rosenberg, S Aradi, A Pruitt Neurology 89 (4), e25-e31, 2017 | | 2017 |
Robert HauserProfessor of Neurology, University of South Florida在 health.usf.edu 的电子邮件经过验证
